Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals

Status Epilepticus Severity Score (STESS)

Andrea O. Rossetti, Giancarlo Logroscino, Tracey Milligan et al. · Journal of Neurology · 2008 · 411 citations · Full text

Medicine, Neurology, Psychiatry +9

Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A (<scp>SV</scp>2A) ligand with preclinical evidence of high brain permeability and fast onset of action

Jean‐Marie Nicolas, Jonas Hannestad, Daniel Holden et al. · Epilepsia · 2015 · 166 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam

Stephen L. Yates, Toufic Fakhoury, Wei Liang et al. · Epilepsy & Behavior · 2015 · 154 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A “Malignant” Variant of Status Epilepticus

Martin Holtkamp, Jalal Othman, Katharina Buchheim et al. · Archives of Neurology · 2005 · 138 citations

Medicine, Anesthesiology, Neurology +9

Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein

Martyn Wood, Michel Gillard · Epilepsia · 2016 · 98 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16